Of 51 cases (43 AITLs and eight PTCL-NOSs) most (90%) had CD30 expression by IHC (range; 1% to 95%), with high levels (>50%) in 14% of cases [20]. The gene discussed is TNFRSF8; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.